Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1985 Nov;331(2-3):247-52.
doi: 10.1007/BF00634245.

Characterization of the muscarinic receptor in human tracheal smooth muscle

Comparative Study

Characterization of the muscarinic receptor in human tracheal smooth muscle

C J van Koppen et al. Naunyn Schmiedebergs Arch Pharmacol. 1985 Nov.

Abstract

Muscarinic receptors in human tracheal smooth muscle were characterized by radioligand binding and functional studies. Specific [3H]-(-)-quinuclidinylbenzilate ([3H]-(-)-QNB) binding to tracheal smooth muscle membranes was reversible, stereoselective and of high affinity (Kd = 47 +/- 4 pmol/l; RT = 920 +/- 120 fmol/g tissue). Inhibition of specific [3H]-(-)-QNB binding by the M-1 selective antagonist pirenzepine was found to occur at relative high concentrations classifying the muscarinic receptor population as belonging to the M-2 subclass. Inhibition of specific [3H]-(-)-QNB binding by muscarinic agonists revealed the presence of high and low affinity sites in nearly equal proportions. 5'-Guanylylimidodiphosphate converted high affinity sites into low affinity sites although its effect was minimal. Log dose-contraction curves of methacholine had Hill coefficients of 1.10 +/- 0.04 with pD2-values of 6.75 +/- 0.02. Inhibition of specific [3H]-(-)-QNB binding by methacholine, however, was best described by a two binding site model with pKi-values considerably lower. The difference between these affinity values points to the presence of substantial receptor reserve.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Mol Pharmacol. 1981 Nov;20(3):519-25 - PubMed
    1. Clin Sci (Lond). 1984 May;66(5):585-90 - PubMed
    1. Histochemistry. 1982;76(2):175-88 - PubMed
    1. Eur J Pharmacol. 1975 Feb;30(2):360-3 - PubMed
    1. Nature. 1980 Jan 3;283(5742):90-2 - PubMed

Publication types

MeSH terms